4
Changes in Ownership
Allogene Therapeutics, Inc. Filed Acc 0001197020-26-000002
Options or other derivatives
- Director acquired 95,400 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
SATO VICKI L · Director
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-06-18 | Grant or award : show line 1 in the form Restricted Stock Unit | +95,400 | 95,400 | D |
Loading xslF345X06/wk-form4_1782246720.xml…